No Data
10 Health Care Stocks With Whale Alerts In Today's Session
Truist Financial Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Announces Target Price $60
Protagonist Therapeutics Analyst Ratings
BTIG Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Maintains Target Price $51
H.C. Wainwright Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Maintains Target Price $50
J.P. Morgan Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Raises Target Price to $51
Companies Like Protagonist Therapeutics (NASDAQ:PTGX) Are In A Position To Invest In GrowthNo Data
No Data
